Verge Genomics

Included for 2024 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, as well as individuals driving unique health initiatives worldwide. The 30 people below h

Fancy making a drug? You may want to create a diagnostic first. Ochre Bio Ltd. has taken a leaf out of the diagnostics industry’s book in its approach to developing RNA-based therapies to treat live

In the more than six years since the US Food and Drug Administration approved Novartis AG ’s Kymriah (tisagenlecleucel) and Kite Pharma’s – now part of Gilead Sciences, Inc. – Yescarta (axicabtagen

Who: Novo Nordisk and Valo Health What: On 25 September, Novo Nordisk and Valo Health announced a deal to use Valo’s artificial intelligence-based platform and real-world patient dataset to enable